Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
PYXS is expected to report earnings to rise 18.33% to -35 cents per share on November 18
Q3'25
Est.
$-0.35
Q2'25
Beat
by $0.04
Q1'25
Missed
by $0.02
Q4'24
Missed
by $1.00
Q3'24
Missed
by $0.03
The last earnings report on August 14 showed earnings per share of -30 cents, beating the estimate of -34 cents. With 86.02K shares outstanding, the current market capitalization sits at 82.48M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PYXS showed earnings on August 14, 2025. You can read more about the earnings report here.